AMI Organics Ltd.
Snapshot View

874.80 -19.35 ▼-2.2%

03 February 2023, 04:01:00 PM
Volume: 11,466

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.amiorganics.com
Market Cap 3,160.37 Cr.
Enterprise Value(EV) 3,135.13 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.26 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 41.15 Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 147.59 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.93 Calculated using Price: 874.80
Dividend Yield 0.35 Period Ending 2022-03
No. of Shares Subscribed 3.64 Cr. 36,437,062 Shares
FaceValue 10
Company Profile
The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.16%
1 Week
-0.38%
1 Month
-8.85%
3 Month
-6.69%
6 Month
-13.33%
1 Year
-13.79%
2 Year
5 Year
10 Year
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 46.43 36.44 39.03 33.73 28.31 39.63 21.28
Return on Capital Employed (%) 35.54 35.91 38.24 33.80 26.25 33.01 24.05
Return on Assets (%) 13.87 12.04 13.99 12.64 12.34 16.74 13.42

Balance Sheet View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 27 39 58 82 112 167 522 544
Non Curr. Liab. 15 15 33 25 25 80 7 8
Curr. Liab. 49 55 65 106 95 166 129 142
Minority Int.
Equity & Liab. 91 109 155 213 232 413 659 695
Non Curr. Assets 25 42 66 89 111 191 223 263
Curr. Assets 66 66 87 124 121 216 429 432
Misc. Exp. not W/O 0 0 2 6 7
Total Assets 91 109 155 213 232 413 659 695

Profit Loss View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 154 160 188 239 240 341 520 574
Other Income 3 0 3 0 3 1 3 5
Total Income 157 160 191 239 242 342 523 579
Total Expenditure -136 -137 -158 -196 -199 -260 -415 -466
PBIDT 21 23 33 42 44 82 108 112
Interest -3 -3 -3 -5 -6 -6 -6 -2
Depreciation -1 -1 -2 -3 -4 -4 -10 -12
Taxation -5 -7 -10 -12 -7 -18 -20 -20
Exceptional Items
PAT 13 12 19 23 27 54 72 77
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 13 12 19 23 27 54 72 77
Adjusted EPS 84 80 123 22 26 6 20 21

Cash Flow View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 10 29 8 15 27 28 -9
Cash Fr. Inv. -14 -19 -25 -21 -24 -101 -124
Cash Fr. Finan. 4 -7 15 6 0 72 140
Net Change 0 3 -2 0 3 -1 8
Cash & Cash Eqvt 0 3 1 0 4 3 10

Shareholding Pattern View Details >>

9 Qtrs 2015-09 (%) 2016-08 (%) 2018-05 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 100.00 98.33 81.00 41.05 41.05 41.05 41.05 39.41 39.41
Public 0.00 1.67 19.00 58.95 58.95 58.95 58.95 60.59 60.59
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 04 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On February 4 2023
The Board of Directors of the Company at their meeting held on Saturday February 4 2023 inter alia considered & approved Unaudited Standalone & Consolidated Financial Results of the Company for the third quarter & nine months ended December 31 2022.
Sat, 04 Feb 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing herewith a Press Release discussing the third quarter & nine months ended financial results as on December 31 2022.
Sat, 04 Feb 2023
Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31 2022
We would like to inform that the Board of Directors at its meeting held on February 4 2023 inter alia considered and approved the Unaudited Standalone and consolidated Financial Results for the third quarter and nine months ended December 31 2022 as recommended by the Audit Committee.

Technical Scans View Details >>

Fri, 03 Feb 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On AMI Organics Ltd.

What is AMI Organics share price?

Can I buy AMI Organics shares now?

What is the Dividend Yield of AMI Organics?

What is the Market Cap of AMI Organics?

What are the key metrics to analyse AMI Organics?

What is the 52 Week High and Low of AMI Organics?

What is the trend of AMI Organics share price?